A German court on Thursday put on hold a patent trial brought by German biotech firm CureVac against domestic rival BioNTech ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Opko Health (OPK – Research Report) and ...

BioNTech SE is revising plans to build a manufacturing network of vaccine plants in three countries in Africa, just over a ...

By Robb M. Stewart Canada's health regulator cleared the latest Covid-19 shot from Pfizer and partner BioNTech, giving its approval to a second ...

Germany's BioNTech announced on Monday a partnership with a global coalition for up to $90 million in funding to support the ...

BioNTech says it is broadening activities in Africa amid reports the German biopharma is reversing manufacturing plans in the ...

CET/CEST The issuer is solely responsible for the content of this announcement. Regional Court Düsseldorf postpones infringement ruling on four intellectual property rights in lawsuit filed by CureVac ...

Health Canada has authorized the use of the Pfizer Comirnaty COVID-19 vaccine targeting the Omicron XBB.1.5 subvariant for ...

The COVID-19 pandemic highlighted a need for local production of vaccines. Now, German pharma company BioNTech has said it ...

The updated vaccine (XBB.1.5 variant-adapted monovalent COVID-19 vaccine) is now authorized in Canada for individuals 6 months of age and olderThe updated vaccine is administered as a single dose for ...

OTTAWA — Health Canada has authorized Pfizer-BioNTech's updated COVID-19 vaccine for people six months and older. The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.

CEPI will provide funding of up to $90 million to support the development of vaccine candidates which is based on BioNTech's ...